Pages that link to "Q68069838"
Jump to navigation
Jump to search
The following pages link to Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation (Q68069838):
Displaying 50 items.
- Pulmonary arterial hypertension: a comparison between children and adults (Q27687320) (← links)
- Pulmonary arterial hypertension associated with congenital heart disease and Eisenmenger syndrome: current practice in pediatrics (Q28085572) (← links)
- The vascular endothelium and human diseases (Q28302238) (← links)
- The adult patient with eisenmenger syndrome: a medical update after dana point part I: epidemiology, clinical aspects and diagnostic options (Q30473252) (← links)
- BMP-9 induced endothelial cell tubule formation and inhibition of migration involves Smad1 driven endothelin-1 production (Q31047574) (← links)
- Circulating endothelin in children with congenital heart disease (Q33612430) (← links)
- Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. (Q33675630) (← links)
- Endothelin-1 and serotonin: mediators of primary and secondary pulmonary hypertension? (Q33709599) (← links)
- Severe pulmonary arterial hypertension associated with congenital cardiac shunts: evolution under specific treatment (Q33786574) (← links)
- Pulmonary hypertension: pathophysiology as a basis for clinical decision making (Q33794815) (← links)
- Current management of patients with pulmonary hypertension and right ventricular insufficiency (Q34027507) (← links)
- Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity (Q34118521) (← links)
- Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan (Q34133301) (← links)
- Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension (Q34466439) (← links)
- The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? (Q34996430) (← links)
- Endothelin and endothelin receptor antagonists in systemic rheumatic disease (Q35127435) (← links)
- Serum endothelin-1 and transforming growth factor-beta levels in the newborns with respiratory distress (Q35161463) (← links)
- Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology (Q35665717) (← links)
- Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. (Q35785931) (← links)
- Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection (Q35890439) (← links)
- Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodynamics in idiopathic pulmonary fibrosis. (Q36390205) (← links)
- Oxidative stress and the development of endothelial dysfunction in congenital heart disease with increased pulmonary blood flow: lessons from the neonatal lamb (Q36480016) (← links)
- Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension (Q36516814) (← links)
- Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling. (Q36549041) (← links)
- Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases (Q36577383) (← links)
- Oxidative and nitrosative stress in pediatric pulmonary hypertension: roles of endothelin-1 and nitric oxide (Q36627420) (← links)
- Lactate, endothelin, and central venous oxygen saturation as predictors of mortality in patients with Tetralogy of Fallot (Q36987929) (← links)
- Polymorphism in the angiotensin II type 1 receptor (AGTR1) is associated with age at diagnosis in pulmonary arterial hypertension (Q37015627) (← links)
- Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment (Q37159329) (← links)
- An open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease (Q37195331) (← links)
- Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review (Q37215048) (← links)
- HLA-B35 upregulates endothelin-1 and downregulates endothelial nitric oxide synthase via endoplasmic reticulum stress response in endothelial cells (Q37332304) (← links)
- Chronic inhibition of PPAR-γ signaling induces endothelial dysfunction in the juvenile lamb (Q37414446) (← links)
- Advances in diagnosis and treatment of pulmonary arterial hypertension in neonates and children with congenital heart disease (Q37689588) (← links)
- Cardiac biomarkers in children with congenital heart disease (Q38603770) (← links)
- A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy. (Q38906301) (← links)
- The PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo (Q39684983) (← links)
- Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung. (Q40588101) (← links)
- Endothelins. A potential target for pharmacological intervention in diseases of the elderly (Q40760247) (← links)
- Endothelin-1: Possible implications in pulmonary vascular disease (Q41563113) (← links)
- Right ventricular diastolic performance: Compliance characteristics with focus on pulmonary hypertension, right ventricular hypertrophy, and calcium channel blockade (Q41715335) (← links)
- Eisenmenger syndrome (Q42244540) (← links)
- Coagulation and fibrinolytic parameters in patients with pulmonary hypertension (Q42523655) (← links)
- EndothelinB receptor-mediated contraction in human pulmonary resistance arteries (Q42580622) (← links)
- Hypoxia mediates mutual repression between microRNA-27a and PPARγ in the pulmonary vasculature (Q42593185) (← links)
- Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619. (Q43174447) (← links)
- ET(A) receptors are the primary mediators of myofilament calcium sensitization induced by ET-1 in rat pulmonary artery smooth muscle: a tyrosine kinase independent pathway. (Q43192104) (← links)
- Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow (Q44099447) (← links)
- Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease (Q44686729) (← links)
- Relationship between endothelin-1 extraction in the peripheral circulation and systemic vascular resistance in patients with severe congestive heart failure (Q48286421) (← links)